Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0058 | 0.0271 | 0.0313 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.1224 | 0.3057 |
Onchocerca volvulus | 0.0058 | 0.0271 | 0.217 | |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0413 | 0.4004 | 0.4729 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0228 | 0.2059 | 0.2054 |
Entamoeba histolytica | hypothetical protein | 0.0044 | 0.0121 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0287 | 0.2677 | 0.2672 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0058 | 0.0271 | 0.0264 |
Loa Loa (eye worm) | MBCTL1 | 0.0066 | 0.0355 | 0.0886 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0413 | 0.4004 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0271 | 0.0676 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0058 | 0.0271 | 0.0264 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0044 | 0.0121 | 0.0115 |
Onchocerca volvulus | 0.0058 | 0.0277 | 0.2226 | |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0413 | 0.4004 | 0.4001 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0413 | 0.4004 | 0.5 |
Brugia malayi | mbt repeat family protein | 0.0058 | 0.0271 | 0.0661 |
Entamoeba histolytica | hypothetical protein | 0.0044 | 0.0121 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0044 | 0.0121 | 0.0136 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0277 | 0.0678 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.1224 | 0.3057 |
Entamoeba histolytica | hypothetical protein | 0.0044 | 0.0121 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0413 | 0.4004 | 0.5 |
Brugia malayi | hypothetical protein | 0.0149 | 0.1224 | 0.3047 |
Entamoeba histolytica | hypothetical protein | 0.0044 | 0.0121 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0044 | 0.0121 | 0.0136 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0413 | 0.4004 | 0.5 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0058 | 0.0271 | 0.0313 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0413 | 0.4004 | 0.5 |
Brugia malayi | mbt repeat family protein | 0.0058 | 0.0271 | 0.0661 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0413 | 0.4004 | 1 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0413 | 0.4004 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0413 | 0.4004 | 0.5 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0058 | 0.0271 | 0.0313 |
Onchocerca volvulus | Huntingtin homolog | 0.0149 | 0.1224 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0006 | 0.0016 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0413 | 0.4004 | 0.4729 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0066 | 0.0355 | 0.0412 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0006 | 0.0016 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0413 | 0.4004 | 0.4729 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0066 | 0.0355 | 0.0872 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0413 | 0.4004 | 0.5 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0058 | 0.0271 | 0.0676 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0228 | 0.2059 | 0.2428 |
Brugia malayi | hypothetical protein | 0.0287 | 0.2677 | 0.668 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0006 | 0.0016 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0058 | 0.0271 | 0.0313 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0837 | 0.846 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0044 | 0.0121 | 0.0136 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0287 | 0.2677 | 0.3159 |
Brugia malayi | MAP kinase sur-1 | 0.0413 | 0.4004 | 1 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0058 | 0.0271 | 0.0313 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0277 | 0.0321 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0413 | 0.4004 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0413 | 0.4004 | 0.4001 |
Schistosoma mansoni | hypothetical protein | 0.0352 | 0.3359 | 0.3966 |
Loa Loa (eye worm) | hypothetical protein | 0.0287 | 0.2677 | 0.6685 |
Onchocerca volvulus | Huntingtin homolog | 0.0149 | 0.1224 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0413 | 0.4004 | 0.5 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0066 | 0.0355 | 0.0412 |
Brugia malayi | hypothetical protein | 0.0044 | 0.0121 | 0.0287 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0413 | 0.4004 | 0.5 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0413 | 0.4004 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0355 | 0.0886 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0066 | 0.0355 | 0.0349 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0413 | 0.4004 | 0.5 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0058 | 0.0271 | 0.217 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0066 | 0.0355 | 0.0412 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0066 | 0.0355 | 0.0349 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0837 | 0.846 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0413 | 0.4004 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0277 | 0.0321 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0837 | 0.846 | 0.8459 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.